Vanguard Capital Management
NEO icon

Vanguard Capital Management’s NeoGenomics NEO Stock Holding History

Vanguard Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.1M Buy
5,763,017
+107,194
+2% +$1.03M ﹤0.01% 1651
2026
Q1 		$42M Buy
+5,655,823
New +$59.5M ﹤0.01% 1946

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's NEO Position: Q2 2026 in Review

Vanguard Capital Management increased its NeoGenomics (NEO) stake by 1.9% in Q2 2026, buying an estimated $1.03M and bringing the position to 5,763,017 shares worth $84.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1651.

Vanguard Capital Management first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 264 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Vanguard Capital Management held 5,763,017 shares of NeoGenomics worth $84.1M as of Q2 2026.
  • Vanguard Capital Management bought 107,194 NeoGenomics shares in Q2 2026, an estimated $1.03M.
  • NeoGenomics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1651 holding.
  • Vanguard Capital Management first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
  • 264 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.